METROPOLITAN LIFE INSURANCE CO/NY - BROOKLYN IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 61 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q3 2021$80,082
-46.2%
8,611
+4.1%
0.00%
-50.0%
Q2 2021$148,979–8,272–0.00%–
 Download
Other shareholders

There were no reported owners of BROOKLYN IMMUNOTHERAPEUTICS in Q4 2021.

NameSharesValueWeighting ↓
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders